ACI’s 12th Maximizing Pharmaceutical Patent Life Cycles Conference

August 3, 2011

The American Conference Institute will be holding its 12th annual “Maximizing Pharmaceutical Patent Life Cycles” conference in New York City from October 3-5, 2011.  A copy of the conference program is available here.  Hyman, Phelps & McNamara, P.C.’s Kurt R. Karst will be presenting at the conference in a session titled “REMS Studies and Generic Entry: Exploring the Latest Regulatory Conundrum Affecting Pharmaceutical Patent Life Cycle Strategies.”  (We’ve previously posted on this topic here.)

The conference will include presentations from key representatives from the PTO (invited), FTC and FDA (invited), an update on biosimilars, in-depth discussions on life-cycle management developments including, analyses of recent critical cases affecting patent life cycle planning, and much more.

FDA Law Blog is a conference media partner.  As such, we can offer FDA Law Blog readers a special $200 discount off the current price tier (which expires this Friday).  The discount code is: FLB 200.  We look forward to seeing you at the conference.